XLerateHealth Awarded $2.5M NIH Phase IIB Grant to Accelerate National Expansion of Its Enterprise Commercialization Engine
XLerateHealth, LLC, a nationally recognized healthcare and life science commercialization accelerator based in Louisville, Kentucky, has been awarded the first phase of a $2.5 million Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) through the IDeA Regional Entrepreneurship Development (I-RED) Program (Award Number R44GM148083).
